Asymmetric Synthesis of Akt Kinase Inhibitor Ipatasertib
Author:
Affiliation:
1. Department of Pharma Technical Development Small Molecules, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.orglett.7b02228
Reference22 articles.
1. The Akt/PKB pathway: molecular target for cancer drug discovery
2. AKT/PKB Signaling: Navigating Downstream
3. An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt
4. Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors
5. Synthesis of Akt Inhibitor Ipatasertib. Part 1. Route Scouting and Early Process Development of a Challenging Cyclopentylpyrimidine Intermediate
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of Novel Pyridine and Pyrimidine Clubbed Bisindoles as Inhibitors of AKT Pathway;ChemistrySelect;2024-07-17
2. Excelzyme: A Swiss University-Industry Collaboration for Accelerated Biocatalyst Development;CHIMIA;2024-03-27
3. Biocatalyst Immobilization and Process Intensification: Production of (S)-Piperazine-2-carboxylic Acid Dihydrochloride;Organic Process Research & Development;2024-03-19
4. Effective engineering of a ketoreductase for the biocatalytic synthesis of an ipatasertib precursor;Communications Chemistry;2024-02-28
5. Industrial asymmetric biocatalysis;Biocatalysis in Asymmetric Synthesis;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3